Scopus BioPharma Inc. - SCPS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2022 · Q2 2022
Value (USD)
Total reported value ($000)
$89K
QoQ value delta ($000)
-$146K (-62.13%)
Implied price effect (QoQ)
-44.24%
Shares
Total shares
374,685
QoQ shares delta
-177,017 (-32.09%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SCPS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2022)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 52 217,078 0.0%
RENAISSANCE TECHNOLOGIES LLC 15 61,104 0.0%
Tower Research Capital LLC (TRC) 6 26,533 0.0%
STATE STREET CORP 5 20,729 0.0%
NORTHERN TRUST CORP 3 12,516 0.0%
FIRST MANHATTAN CO 3 13,100 0.0%
Y-Intercept (Hong Kong) Ltd 2 10,940 0.0%
JPMORGAN CHASE & CO 1 5,000 0.0%
UBS Group AG 1 2,254 0.0%
Compagnie Lombard Odier SCmA 1 4,360 0.0%
WELLS FARGO & COMPANY/MN 0 69 0.0%
HARBOUR INVESTMENTS, INC. 0 1,000 0.0%
MORGAN STANLEY 0 2 0.0%